Marcel Salive still remembers the data point that surprised even the most seasoned researchers: after more than 20 years, adults with prediabetes who had once participated in an intensive lifestyle program were still carrying a powerful shield against chronic illness. The landmark NIH study, which began in 1996 and followed 1,173 high-risk participants across 27 U.S. sites, reveals that simple, sustained changes in diet and exercise can dramatically reduce the odds of developing multiple chronic conditions—a growing public health crisis known as multimorbidity. With 85% of participants eventually facing two or more chronic diseases, the findings underscore how rare and vital preventive strategies truly are.
Prediabetes affects an estimated 96 million American adults, many of whom are at heightened risk not just for type 2 diabetes but for a cascade of health problems including heart disease, chronic kidney disease, and depression. Yet few interventions have been proven to delay or prevent this domino effect. The Diabetes Prevention Program (DPP) was originally designed to test whether lifestyle changes or metformin could prevent diabetes. Participants in the lifestyle group received 16 individual sessions followed by monthly meetings for two years, aiming for at least a 7% weight loss through reduced calorie and fat intake and 150 minutes of weekly physical activity. Even after the trial’s formal end, all participants gained access to group lifestyle sessions, with the original intervention group receiving biannual boosters.
By the time follow-up concluded in 2021, the long-term impact was clear. Those in the lifestyle group had a 21% lower risk of developing two chronic conditions and a 25% lower risk of developing three, compared to the placebo group. The benefits held strong even when diabetes was excluded from the analysis, suggesting broader protective effects across conditions like hypertension, arthritis, COPD, and dementia. In contrast, metformin showed no statistically significant reduction in multimorbidity risk over time—highlighting that while medication may help manage blood sugar, it doesn’t replicate the systemic benefits of lifestyle change.
These results aren’t just statistically significant—they’re humanly transformative. As Dr. Griffin P. Rodgers of the NIDDK notes, lifestyle interventions are not only effective but safe and cost-effective, offering a scalable path to reduce both personal suffering and national healthcare costs. With chronic diseases accounting for 90% of the nation’s $4.1 trillion annual healthcare spending, the ripple effects of such prevention could be profound. The study offers more than data; it offers direction—a roadmap rooted not in pharmaceuticals, but in daily choices around food, movement, and community support. As the U.S. grapples with rising rates of preventable illness, this enduring benefit of a years-ago lifestyle program stands as a quiet beacon of hope.